Nektar Says Eli Lilly Botched Autoimmune Drug Trials

By Ayden Crosby · August 7, 2023, 7:47 PM EDT

Nektar Therapeutics is accusing Eli Lilly of butchering and delaying clinical trials for a new autoimmune-disease drug the two companies agreed to develop together, claiming the pharma giant ruined the drug's...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Nektar Therapeutics v. Eli Lilly & Co

Case Number

3:23-cv-03943

Court

California Northern

Nature of Suit

Contract: Other

Date Filed

August 07, 2023

Featured Stories

What To Watch As Justices Take On 'Skinny Label' Case No Photo Available

Ryan Davis

The U.S. Supreme Court will hear arguments Wednesday on whether to permit a patent suit over a generic heart drug using a so-called sk... (more story)

Courts Rule On J&J Investor Class, Abortion Rights And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at the U.S. Supreme Court's rejection of a petition by Johnson & Johnson challenging the certificati... (more story)

3 Key Takeaways From The RFK Jr. Hearings No Photo Available

Yeji Jesse Lee

Experts told Law360 that Health and Human Services Secretary Robert F. Kennedy Jr. appears to be avoiding “politically unsavory” issue... (more story)